Best Practices Report.PART 1 Primary Protection: Enhancing Health Care Resilience for a Changing Climatei Primary Protection: EnhancingU.S. Department of Health and Human Services
Available in English, French, Spanish, Russian, Chinese, Arabic and Portugues
Shoman et al. Globalization and Health (2017) 13:1 DOI 10.1186/s12992-016-0224-2
Disaster Preparedness Training Programme
Disaster Preparedness Training Programme
Disaster Preparedness Training Programme
This is a pre-deployment training, tailored specially to the Ebola outbreak in West Africa, offered to WHO personnel, consultants, and key partners. The material covered in modules 1-4 is applicable and useful to frontline response workers, national and international. Only Module 5, which focuses on... operational aspects - the code of conduct for international civil servants and human resources arrangements for WHO deployees, are specifically geared to all internationally recruited personnel and to WHO deployees respectively
more
A Toolkit for Implementation. Module 5: Finalizing, monitoring and evaluating the IFC action plan
Recommendations on action and research for:
a) preventing early pregnancy
b) preventing poor reproductive outcomes
The need for a roadmap for risk assessment stemmed from the lack of standardised and systematic effort to national risk assessment effort to date. The road map details the process, activities necessary for each step and the availability and accessibility of technical and financial resources, and coo...rdination mechanisms for the implementation f a national risk assessment.
more
The Global Appeal provides updated information for government, private donors, partners and other readers interested in UNHCR's priorities and budgeted activities for 2021 to protect and improve the lives of tens of millions of people of concern (refugees, internally displaced people, stateless pers...ons and others)
more
BJPSYCH INTERNATIONALVOLUME 12NUMBER 4NOVEMBER 2015
Globally each year, millions of people suffer illness or lose their lives because the vaccines, medicines and diagnostic tests that they need are either unavailable or unaffordable – and this lack of access to medicine is acute in low- and middle-in-
come countries (LMICs). While the COVID-19 pan...demic laid this inequity bare, it also saw the pharmaceutical industry develop and bring new vaccines and treat- ments to market at unprecedented speed. As the world emerges from the worst
of this crisis, pharmaceutical companies are now at an important juncture, where lessons learned from the pandemic can prove pivotal in finding solutions to bridge long-standing gaps in access to medicine in LMICs.
more
Scientific Brief 9 July 2020